In vivo antitumor effect of retrovirus-mediated gene transfer of the adenovirus E1a gene

Cancer Gene Therapy

Volumn 5, Issue 4, 1998, Pages 215-224

  Sánchez Prieto, Ricardo ^a   Quintanilla, Miguel ^b   Martín, Pilar ^a   Lleonart, Matilde ^a   Cano, Amparo ^b   Dotto, G Paolo ^c   Ramón Y Cajal, Santiago ^a  

^a HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

^b CSIC   (Spain)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Adenovirus E1a; Gene therapy; Retrovirus; Tumorigenicity

Indexed keywords

ANTINEOPLASTIC AGENT; E1A PROTEIN;

ANIMAL; ARTICLE; CANCER TRANSPLANTATION; CELL CULTURE; CELL TRANSPLANTATION; DRUG SCREENING; EXPERIMENTAL NEOPLASM; GENE EXPRESSION REGULATION; GENE TRANSFER; GENETIC TRANSFECTION; GENETICS; METABOLISM; MOUSE; NUDE MOUSE; PATHOLOGY; SQUAMOUS CELL CARCINOMA; VIROLOGY;

ADENOVIRUS E1A PROTEINS; ANIMALS; ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; CELL TRANSPLANTATION; DRUG SCREENING ASSAYS, ANTITUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE TRANSFER TECHNIQUES; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; NEOPLASMS, EXPERIMENTAL; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0032111289     PISSN: 09291903     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Anderson WF. Human gene therapy. Science. 1992;256: 803-808.
2. Miller AD. Human gene therapy comes of age. Nature. 1992;357:455-460.
3. Molten FL. Drug sensitivity (suicide) genes for selective cancer chemotherapy. Cancer Gene Ther. 1994;1:279-287.
4. Liu T-J, Zhang WW, Taylor DL, Roth JA, Goepfert H, Clayman GL. Growth suppression of human head and neck cells by introduction of a wild type p53 gene via a recombinant adenovirus. Cancer Res. 1994;54:3662-3667.
5. Yang CH, Cirielli C, Capogrossi MC, Passantini A. Adenovirus-mediated wild-type p53 induces apoptosis and suppresses tumorigenesis of prostatic tumor cells. Cancer Res. 1995;55:4210-4213.
6. Clayman GL, El-Naggar AK, Roth JA, Zhang WW, Goepfert H, Taylor DL, Liu T-J. In vivo molecular therapy with p53 adenovirus for microscopic residual head and neck squamous carcinoma. Cancer Res. 1995;55:1-6.
7. Gomez-Manzano C, Fueyo J, Kyritsis AP, Steck PA, Roth JA, McDonnell TJ, Steck KD, Levin VA, Yung WKA. Adenovirus-mediated transfer of the p53 gene produces rapid and generalized death of human glioma cells via apoptosis. Cancer Res. 1996;56:694-699.
8. Roth JA, Nguyen D, Lawrence DD, Kemp BL, Carrasco CH, Ferson DZ, Hong WK, Komaki JC, Nesbitt JC, Pisters KMW, Putnam JB, Schea R, Shin DM, Walsh GL, Dolormente MM, Han CI, Martin FD, Yen N, Xu K, Stephens LC, McDonnell TJ, Mukhopadhyay T, Cai D. Retrovirus-mediated wild type p53 gene transfer to tumors of patients with lung cancer. Nat Med. 1996;2:985-991.
9. Branton PE, Bayley ST, Graham FL. Transformation by human adenoviruses. Biochem Biophys Acta. 1985;780:67-94.
10. Spindler KR, Berk AJ. Rapid intracellular turnover of adenovirus 5 early region IA proteins. J Virol. 1984;52: 706-710.
11. Boulanger PA, Blair GE. Expression and interaction of human adenovirus oncoproteins. J Biochem. 1991;275:281-299.
12. Bayley ST, Mymryk JS. Adenovirus E1a protein and transformation. Int J Oncol. 1994;5:425-444.
13. Webster KA, Muscat GE, Kedes L. Adenovirus E1a products suppress myogenic differentiation and inhibit transcription from muscle-specific promoters. Nature. 1988;322:553-557.
14. Ramón y Cajal S, Sánchez-Prieto R, Anaya A. A genetic model for undifferentiated cell tumor formation: similar tumors formed by different cell lines transformed by the E1a oncogene. Histol Histopathol. 1995;10:811-820.
15. Missero C, Calautti E, Eckner R, Chin J, Tsai LH, Livingstone DM, Dotto GP. Involvement of the cell cycle inhibitor cip1/waf1 and the E1A-associated p300 protein in terminal differentiation. Proc Natl Acad Sci USA. 1995;92: 5451-5455.
16. Lowe SW, Ruley HE. Stabilization of the p53 tumor suppressor is induced by adenovirus 5E1a and accompanies apoptosis. Genes Dev. 1993;7:535-545.
17. Marchetti E, Romero J, Sanchez R, Vargas JA, Lacal JC, Ramón y Cajal S. Oncogenes and cellular sensitivity to radiotherapy: a study on murine keratinocytes transformed by v-H-raj, v-myc, neu, adenovirus E1a and p53 mutants. Int J Oncol. 1994;5:611-618.
18. Sánchez-Prieto R, Vargas JA, Carnero A, Marchetti E, Romero J, Durantez A, Lacal JC, Ramón y Cajal S. Modulation of cellular chemoresistance in keratinocytes by activation of different oncogenes. Int J Cancer. 1995;60: 235-243.
19. Sánchez-Prieto R, Lleonart M, Ramón y Cajal S. Lack of correlation between p53 protein level and sensitivity of DNA-damaging agents in keratinocytes carrying adenovirus E1a mutants. Oncogene. 1995;11:675-682.
20. Sánchez-Prieto R, Quintanilla M, Cano A, Lleonart M, Martín P, Anaya A, and Ramón y Cajal S. Carcinoma cell lines become sensitive to DNA-damaging agents by the expression of the adenovirus E1a gene. Oncogene. 1996; 13:1083-1092.
21. Mymryk JS. Tumor suppressive properties of the adenovirus 5 E1a oncogene. Oncogene. 1996;13:1581-1589.
22. Teodoro JG, Shore GC, Branton PE. Adenovirus E1a proteins induce apoptosis by both p53-dependent and p53-independent mechanisms. Oncogene. 1995;11:467-474.
23. Routes JM, Li H, Bayley ST, Ryan S, Klemm DJ. Retrovirus-mediated wild-type p53 gene transfer to tumors of patients with lung cancer. J Immunol. 1996;156:1055-1061.
24. Chen MJ, Holskin B, Strickler J, Gorniak J, Clark MA, Johnson PJ, Mithco M, Shalloway D. Induction by E1a oncogene expression of cellular susceptibility to lysis by TNF. Nature. 1987;330:581-583.
25. Krantz CK, Routes BA, Quinlan MP, Cook JL. E1A second exon requirements for induction of target cell susceptibility to lysis by natural killer cells: implications for the mechanism of action. Virology. 1996;217:23-32.
26. Shisler J, Duerksen-Hughes P, Hermiston TM, Wold WSM, Gooding LR. Induction of susceptibility to tumor necrosis factor by E1A is dependent on binding to either p300 or p105-Rb and induction of DNA synthesis. J Virol. 1996;70:68-77.
27. Whyte P, Williamson NM, Harlow E. Cellular targets for transformation by the adenovirus E1A protein. Cell. 1988; 45:67-75.
28. Missero C, Ramón y Cajal S, and Dotto GP. Escape from transforming growth factor β control and oncogene cooperation in skin tumor development. Proc Nail Acad Sci USA. 1991;88:1295-1300.
29. Eckner R, Ewen ME, Newsome D, Gerdes M, DeCaprio JA, Lawrence JB, Liwsitong DM. The molecular cloning and functional analysis of the adenovirus Ela-associated 300-kDa protein (p300) reveals a protein with properties of a transcriptional adaptor. Genes Dev. 1994;8:869-884.
30. Kraus VB, Inostroza JA, Yeung K, Reinberg D, Nevis J. Interaction of the Dr1 inhibitory factor with the TATA binding protein is disrupted by the adenovirus E1a. Proc Natl Acad Sci USA. 1994;91:6279-6282.
31. Liu F, Green MR. Promoter targeting by adenovirus E1a through interaction with different cellular DNA-binding domains. Nature. 1996;368:520-525.
32. Mymryk JS, Shire K, Bayley ST. Induction of apoptosis by adenovirus 5 E1a in rat cells requires a proliferation block. Oncogene. 1994;9:1187-1193.
33. Lewis BA, Tullis G, Seto E, Horiskohi N, Weinmann R, Shen T. Adenovirus E1A proteins interact with the cellular YY1 transcription factor. J Virol 1995;69:1628-1636.
34. Lundblad JR, Kwok RP, Laurance ME, Harter ML, Goodman RH. Adenoviral Ela-associated protein p300 as a functional homologue of the transcriptional co-activator GBP. Nature. 1995;374:85-87.
35. Frisch SM. Antioncogenic effect of adenovirus E1a in human tumor cells. Proc Natl Acad Sci USA. 1991;88:9077-9081.
36. Ramón y Cajal S, Marchetti E, Missero C, Dotto GP. Dermal fibroblast tumor suppression of ras-transformed keratinocytes is associated with induction of squamous cell differentiation. Am J Pathol. 1994;145:846-855.
37. Yu D, Martin A, Xia W, Sorgi F, Huang L, Hung M-C. Liposome-mediated in vivo E1a gene transfer suppressed dissemination of ovarian cancer cell that overexpress HER-2/neu. Oncogene. 1995;11:1383-1388.
38. Zhang Y, Yu D, Xia W, Hung MC. Her-2/neu-targeting cancer therapy via adenovirus-mediated E1a delivery in an animal model. Oncogene. 1995;10:1947-1954.
39. Brown K, Quintanilla M, Ramiden M, Kerr IB, Young S, Balmain A. V-ras genes from Harvey and BALB murine sarcoma viruses can act as initiators at two-stage mouse skin carcinogenesis. Cell. 1986;46:447-456.
40. Burns PA, Kemp CJ, Gannon JV, Lana AP, Bremmer R, Balmain A. Loss of heterozygosis and mutational alterations of the p53 gene in skin tumors of interspecific hybrid mice. Oncogene. 1991;6:2363-2369.
41. Dotto GP, Moellman G, Ghosh S, Edwards M, Halaban R. Transformation of murine melanocytes by basic fibroblast growth factor cDNA and oncogenes and selective suppression of the transformed phenotype in a reconstituted cutaneous environment. J Cell Biol. 1989;109:3115-3128.
42. Huang HJS, Yee JK, Shew JY, Chen PL, Bookestein R, Friedman T, Lee EYH, Lee WH. Suppression of the neoplastic phenotype by replacement of the RB gene in human cancer cells. Science. 1988;242:1563-1566.
43. Huber BE. Gene therapy for neoplastic diseases. In Huber BE, Lazo JS, eds. Annals of the New York Academy of Sciences. New York: The New York Academy of Sciences; 1994:6-11.
44. Mastrangelo MJ, Berd D, Nathan FE, Lattime EC. Gene therapy for human cancer: an essay for clinicians. Semin Oncol. 1996;23:2-21.
45. Culver KW, Ram Z, Wallbridgge S, Ishii H, Olfield EH, Blase RM. In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors. Science. 1992;256:1550-1552.
46. Freeman SM, Whartenby KA, Freeman JL, Abboud CN, Marrogi AJ. In situ use of suicide genes for cancer therapy. Semin Oncol. 1996;23:31-45.
47. Heise C, Sampson-Johannes A, Williams A, McCormick F, Von Hoff DD, Kirn DH. ONYX-015, an E1B gene-attenuated adenovirus, causes tumor-specific cytolysis and antitumoral efficacy that can be augmented by standard chemotherapeutic agents. Nat Med. 1997;3:639-645.
48. Frisch SM, Dolter KE. E1a-mediated tumor suppression by a c-erbB-2/neu-independent mechanism. Cancer Res. 1995;55:5551-5555.
49. Frisch SM, Reich R, Collier IE, Genrich T, Martin G, Goldberg GI. Adenovirus E1a represses protease gene expression and inhibits metastasis of human cells. Oncogene. 1990;5:75-83.
50. Missero C, Serra C, Stenn K, Dotto GP. Skin-specific expression of a truncated E1a oncoprotein binding to p105-rb leads to abnormal hair follicle maturation without increased epidermal proliferation. J Cell Biol. 1993;121: 1109-1120.
51. Chen H, Yu D, Chinadurai G, Karunagaran D, Hung M-C. Mapping of adenovirus 5 E1a domains responsible for suppression of neu-mediated transformation via transcriptional repression of neu. Oncogene. 1997;14:1965-1971.
52. Frisch SM, Francis H. Disruption of epithelial cell-matrix interactions induces apoptosis. J Cell Biol. 1994;124:619-626.